| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
General Counsel
1 company
Gibbs Michael Terrence is a General Counsel at T2 Biosystems, Inc.. Recent SEC Form 4 filings include 1 buy and 8 sells.
Estimated insider holdings value: $0 based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 28, 2023 | TTOO T2 Biosystems, Inc. | General Counsel | Sell | 239 | $0.48 | $114.96 | -3.5% | |
| Feb 28, 2023 | TTOO T2 Biosystems, Inc. | General Counsel | Sale+OE | 3,730 | $0.62 | $2,329.40 | -24.2% | |
| Apr 7, 2022 | TTOO T2 Biosystems, Inc. | General Counsel | Buy | 10,000 | $0.49 | $4,900.00 | +6.4% | |
| Mar 25, 2021 | TTOO T2 Biosystems, Inc. | General Counsel | Sale+OE | 8,758 | $1.56 | $13,662.48 | -10.7% | |
| Feb 23, 2021 | TTOO T2 Biosystems, Inc. | General Counsel | Sale+OE | 7,280 | $2.06 | $14,996.80 | -10.0% | |
| Feb 24, 2020 | TTOO T2 Biosystems, Inc. | General Counsel | Sale+OE | 5,808 | $0.82 | $4,762.56 | -8.7% | |
| Feb 11, 2020 | TTOO T2 Biosystems, Inc. | General Counsel | Sale+OE | 3,200 | $0.77 | $2,464.00 | -5.4% | |
| Feb 3, 2020 | TTOO T2 Biosystems, Inc. | General Counsel | Sell | 3,283 | $0.88 | $2,889.04 | -5.7% |